Mai Nguyen New Product Planning Professor Patton 3/5/14 Metabical: Pricing‚ Packaging‚ and Demand Forecasting for a New Weight-Loss Drug Case 1. How does Metabical compare to current weight-loss options? There are only several other weight-loss options in the market competing with Metabical. The first is prescription drugs. These are prescribed for use only by obese and severely obese individuals. This meant that only individuals with BMI of over 30 who were prescribed weight-loss drugs
Premium Obesity Medical prescription Drugs
Metabical (Case study) Case Facts • Metabical is a prescription drug produced by Cambridge Sciences Pharmaceuticals (CSP) for weight loss. • It was the first and only prescription drug to obtain FDA approval for weight loss (overweight category) drug. • The company had conducted an elaborate market research program for identifying the target segment and positioning the product. • Competitors: FDA approved OTC drug Alli. • Marketing strategy: – DTC advertising- celebrity endorser‚ TV‚ radio‚
Premium Obesity Food and Drug Administration Marketing
Table Of Contents 1.0 2.0 3.0 Introduction Executive Summary Situation Analysis 3.1 Identification Of The Problem 3.2 Market Analysis 3.3 SWOT Analysis 3.4 Target Market Marketing Communication Strategy 4.1 Marketing Communication Plan/Objectives 4.2 Marketing Budget 4.3 Schedule for Key Marketing Communication Activities 4.4 Promotional Strategies 4.4.1 Advertising Strategies 4.4.2 Promotion and Public Relations 4.4.3 Sales Force 4.4.4 Comprehensive Support Program 4.5 Product Strategies 4.6 Distribution
Premium Marketing Obesity Weight loss
towards both men and women; however‚ a focus on women may be more worthwhile. In terms of weight-loss‚ women exhibit more of a desire to change their overall body image‚ and showcase a motivation to eat‚ look‚ and feel healthier. (See Exhibit 3 in Case Book) Metabical’s age demographic segmentation would have a stronger response from the middle 25-34‚ 35-44‚ and 45-54-age sector that is moderately overweight (BMI of 25-30). These age brackets more likely have the financial means to purchase such
Premium Obesity Weight loss Medical prescription
1. How does Metabical compare to current weight-loss options? Answer: Metabical is revolutionary product and forecasted to be the first FDA approved prescriptive drug for overweight individuals with weight-loss goals. The previous prescriptive drugs have a negative side effects that out weighed its positives. Metabical‚ on the other hand‚ did not display as many negative effects in its trail runs and thus was being strongly endorsed by the medical community. The current weight-loss drugs can be
Premium Obesity Weight loss Cancer
aware of how excess weight is affecting their well-being. These individuals would likely provide personal encouragement to undergo the Metabical process and move from the “think” to the “do” stage. Metabical’s advertisements also provide the “pull” by providing information that is needed to educate consumers on the benefits and points of differentiation that Metabical offers its customers. Health care professionals provide the “push” for individuals to begin taking a prescription drugs for weight
Premium Marketing Health care Weight loss
Case study : Metabical Positining and communication strategy for a new weight-loss drug Question 1 – How should Printup think about the segmentation of potential Metabical consumers? Who is the optimal target consumer? They should target women less than 65 especially (exhibit 2). They seem to be more aware than men to their weight. But most of the population (men and women) are now more conscious that losing weight is important for health. We can talk about normal customers including young
Premium Obesity Weight loss
Case Summary The Cambridge Sciences Pharmaceuticals (“CSP”) is an international healthcare company that had completed successful clinical trials for its newest weight loss prescription drug‚ Metabical. With the final FDA approval expected‚ Metabical’s launch was set for January 2009 and a clear marketing communications strategy needed to be in place before the launch. With 10 years and $400 million spent on research and development‚ it was imperative that CSP positions Metabical correctly in the
Premium Obesity Food and Drug Administration Health care
METABICAL ASSIGNMENT 1. This is an individual assignment. Each student must turn in a one-page worksheet for the Metabical case. Use the template on page 2 of this document. The document may be typed or handwritten. You are welcome to use bullet points. 2. While you may interact with other students on this case‚ the worksheet must be turned in on an individual basis. Your worksheet will impact your class participation grade. 3. The questions under “Points to Ponder” below may be treated as suggested
Premium Health care Advertising Health care provider
METABICAL Problem Statement Cambridge Sciences Pharmaceuticals (CPS) wishes to determine the best possible target market in order to launch Metabical‚ the new weight-loss prescription drug that’s stipulated to be included in their portfolio. Importance of Positioning Strategies It’s important to note that finding the accurate positioning for any product within the market is crucial‚ given that historically when a product is incorrectly placed it tends to lack
Premium Obesity Health care